EVNIN LUKE (CIK 1134657) reported 94 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-07-08). Recent activity: Sell HOWL (35,770 shares), Sell HOWL (107,429 shares), Sell HOWL (157,084 shares), Sell HOWL (76,928 shares), Sell HOWL (20,072 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-08 | Werewolf Therapeutics, Inc. (HOWL) | Director | Sell | 35,770 | $11,446 |
| 2026-07-08 | Werewolf Therapeutics, Inc. (HOWL) | Director | Sell | 107,429 | $33,303 |
| 2026-06-29 | Werewolf Therapeutics, Inc. (HOWL) | Director | Sell | 157,084 | $47,125 |
| 2026-06-10 | Werewolf Therapeutics, Inc. (HOWL) | Director | Sell | 76,928 | $28,463 |
| 2026-06-08 | Werewolf Therapeutics, Inc. (HOWL) | Director | Sell | 20,072 | $8,832 |
| 2026-06-08 | Werewolf Therapeutics, Inc. (HOWL) | Director | Sell | 24,946 | $9,978 |
| 2026-06-08 | Werewolf Therapeutics, Inc. (HOWL) | Director | Sell | 60,547 | $24,219 |
| 2026-06-03 | Werewolf Therapeutics, Inc. (HOWL) | Director | Sell | 80,459 | $37,816 |
| 2026-06-03 | Werewolf Therapeutics, Inc. (HOWL) | Director | Sell | 29,595 | $13,318 |
| 2026-06-03 | Werewolf Therapeutics, Inc. (HOWL) | Director | Sell | 29,749 | $12,495 |
| 2026-05-29 | Werewolf Therapeutics, Inc. (HOWL) | Director | Sell | 32,556 | $14,650 |
| 2026-05-29 | Werewolf Therapeutics, Inc. (HOWL) | Director | Sell | 27,698 | $12,741 |
| 2026-05-29 | Werewolf Therapeutics, Inc. (HOWL) | Director | Sell | 80,852 | $38,809 |
| 2026-05-26 | Werewolf Therapeutics, Inc. (HOWL) | Director | Sell | 36,387 | $15,283 |
| 2026-05-26 | Werewolf Therapeutics, Inc. (HOWL) | Director | Sell | 87,425 | $39,341 |
| 2026-05-26 | Werewolf Therapeutics, Inc. (HOWL) | Director | Sell | 67,950 | $31,936 |
| 2026-05-20 | Werewolf Therapeutics, Inc. (HOWL) | Director | Sell | 22,184 | $11,092 |
| 2026-05-20 | Werewolf Therapeutics, Inc. (HOWL) | Director | Sell | 62,970 | $28,336 |
| 2026-05-20 | Werewolf Therapeutics, Inc. (HOWL) | Director | Sell | 85,895 | $36,935 |
| 2026-05-13 | Werewolf Therapeutics, Inc. (HOWL) | Director | Sell | 44,679 | $24,127 |
| 2026-05-12 | Werewolf Therapeutics, Inc. (HOWL) | Director | Sell | 305,741 | $214,019 |
| 2026-05-12 | Werewolf Therapeutics, Inc. (HOWL) | Director | Sell | 33,948 | $22,745 |
| 2026-05-12 | Werewolf Therapeutics, Inc. (HOWL) | Director | Sell | 67,885 | $43,446 |
| 2026-05-07 | Werewolf Therapeutics, Inc. (HOWL) | Director | Sell | 6,860 | $4,733 |
| 2026-05-07 | Werewolf Therapeutics, Inc. (HOWL) | Director | Sell | 14,635 | $9,659 |
Source: SEC Form 4 filings · as of 2026-07-08